Symposium: Therapeutic Antibody Technology 97

PAIMM paimm at netgate.net
Sun Mar 23 19:12:00 EST 1997


Therapeutic Antibody Technology 97

PLACE/DATE:  Holiday Inn--Union Square, San Francisco, CA; Sept. 21-24,
1997.

Antibodies are a promising form of biotherapy. Four advances have made
possible the facile generation of recombinant therapeutic monoclonal
antibodies:  PCR, bacterial expression, phage display and combinatorial
methods. Pioneers in each of these fields will present their latest
work.  Some monoclonal antibodies have been successfully tested in
clinical trials and this progress will be presented. Many of the world
leaders in these technologies and their application will discuss recent
work in this important and rapidly changing field.

Keynote Address:   Richard A. Lerner,  Scripps Research Institute
=09
Confirmed Speakers:

Carlos Barbas		Scripps	=20
Carl Borrebaeck		Sweden	=20
Dennis Burton		Scripps
Peter Colman		Australia
Brian Dallaire		IDEC=09
Zelig Eshhar		Israel
Neil Greenspan		Case Western=20
Andrew Griffiths	Cambridge, UK
R. Houghten		Torrey Pines
H. Hoogenboom		Netherlands=09
Peter Hudson		CSIRO
Aya Jakobvits		AbGenix	=20
Paula Jardieu		Genentech
Kevin Johnson		CAT
Richard Junghans	Boston
Ton Logtenberg		Netherlands		=20
Wayne Marasco		Harvard
Roy Mariuzza		Maryland	=20
James D. Marks		UCSF
Gordon Moore		SKB
Sherie Morrison		UCLA		=20
Achim Knappik		Morphosys
Paul Parren		Scripps
Ira Pastan		NIH		=20
Andreas Pl=FCckthun	Zurich=09
Michael Pfreudschuh	 Germany
Cary Queen		Protein Design=20
John Reno		NeoRx=09
Jamie Scott		Canada
Tom Smith		Indiana
Anthony Williamson	Scripps	=20
Ian Wilson		Scripps
	=20
 Poster presentations welcome.

Organizers:	James W. Larrick and Dennis Burton=20
Sponsor:	Palo Alto Institute of Molecular Medicine=20
		The Scripps Research Institute, La Jolla, CA
Information:	Palo Alto Institute of Molecular Medicine
		2462 Wyandotte Street
		Mountain View, California 94043, USA
		TEL: (415)--694-1420; FAX:(415)--694-7717; e-mail: PAIMM at netgate.net




More information about the Bionews mailing list